696 related articles for article (PubMed ID: 16260486)
1. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
Lau CM; Broughton C; Tabor AS; Akira S; Flavell RA; Mamula MJ; Christensen SR; Shlomchik MJ; Viglianti GA; Rifkin IR; Marshak-Rothstein A
J Exp Med; 2005 Nov; 202(9):1171-7. PubMed ID: 16260486
[TBL] [Abstract][Full Text] [Related]
2. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
4. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice.
Berland R; Fernandez L; Kari E; Han JH; Lomakin I; Akira S; Wortis HH; Kearney JF; Ucci AA; Imanishi-Kari T
Immunity; 2006 Sep; 25(3):429-40. PubMed ID: 16973388
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
[TBL] [Abstract][Full Text] [Related]
7. Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.
Sang A; Niu H; Cullen J; Choi SC; Zheng YY; Wang H; Shlomchik MJ; Morel L
J Immunol; 2014 Aug; 193(4):1609-21. PubMed ID: 25015835
[TBL] [Abstract][Full Text] [Related]
8. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
9. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
Layer T; Steele A; Goeken JA; Fleenor S; Lenert P
Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of TLR7 and TLR9 in murine SLE.
Santiago-Raber ML; Baudino L; Izui S
J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
[TBL] [Abstract][Full Text] [Related]
11. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.
Nickerson KM; Christensen SR; Shupe J; Kashgarian M; Kim D; Elkon K; Shlomchik MJ
J Immunol; 2010 Feb; 184(4):1840-8. PubMed ID: 20089701
[TBL] [Abstract][Full Text] [Related]
12. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
[TBL] [Abstract][Full Text] [Related]
13. Cutting Edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands.
Pawaria S; Moody K; Busto P; Nündel K; Choi CH; Ghayur T; Marshak-Rothstein A
J Immunol; 2015 Feb; 194(4):1403-7. PubMed ID: 25601924
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
Pawar RD; Ramanjaneyulu A; Kulkarni OP; Lech M; Segerer S; Anders HJ
J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
16. Control of B-cell responses by Toll-like receptors.
Pasare C; Medzhitov R
Nature; 2005 Nov; 438(7066):364-8. PubMed ID: 16292312
[TBL] [Abstract][Full Text] [Related]
17. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
[TBL] [Abstract][Full Text] [Related]
18. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
19. Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells.
Moody KL; Uccellini MB; Avalos AM; Marshak-Rothstein A; Viglianti GA
Methods Mol Biol; 2016; 1390():249-72. PubMed ID: 26803634
[TBL] [Abstract][Full Text] [Related]
20. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.
Herlands RA; Christensen SR; Sweet RA; Hershberg U; Shlomchik MJ
Immunity; 2008 Aug; 29(2):249-60. PubMed ID: 18691914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
